A researcher studying whether cash payments can keep young people with HIV in treatment says federal reviewers at the National Institutes of Health made her abandon her original study design. Dr Jade Pagkas-Bather won her first NIH grant in June 2025, and her account has drawn sharp criticism of how the agency now screens funding requests against the priorities of the Trump administration.
Her project would test monthly payments of $500 to poor, HIV-positive young adults in Chicago. The core question is simple: does steady financial support help patients stay on the antiretroviral medication they need to control the virus? Cash assistance is a long-debated approach to public health, and the trial was designed to answer it with a rigorous comparison.
According to the reporting, the NIH has been reviewing grants for how well they fit the administration's stated priorities. Pagkas-Bather's experience suggests that the review went beyond scientific merit, and that researchers were required to change their plans in ways they believed compromised the work. The Guardian describes the interference in grant-making as Orwellian, a characterization that reflects the concern of scientists that political considerations are shaping which research goes ahead.
The episode highlights a broader worry in the research community: that funding decisions are increasingly influenced by political alignment rather than peer assessment alone. The reporting does not include the full details of the reversal or name every official involved, but it points to a process that has left at least one HIV researcher reworking a study she had already been awarded.